Development of CFTR-knockout monocytic cell line and understanding why patients with CF are vulnerable to Mycobacterium abscessus (MABS) infection (2020–2022)

Grant type:
Australian Cystic Fibrosis Research Trust Innovation Grant
Researchers:
Funded by:
Australian Cystic Fibrosis Research Trust